Understanding dynamics of pandemics

Akın, Levent; Gözel, Mustafa Gökhan

doi:10.3906/sag-2004-133

Cited by 126 publications

(92 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The Spanish flu in 1918, Asian flu in 1957, Hong Kong flu in 1968, and swine flu in 2009 were known as pandemics with varying morbidity and mortality. As a result, pandemics bring many problems, both in individual and societal levels [3] .…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy

Gul

Atakli

2021

Epilepsy & Behavior

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…As in previous pandemics, epidemics such as COVID-19 have many negative effects on both society and individuals. Chronic diseases such as epilepsy are likely to be affected by these epidemics, and we have little knowledge on this subject [3] .…”

Section: Introductionmentioning

confidence: 99%

Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy

Gul

Atakli

2021

Epilepsy & Behavior

View full text Add to dashboard Cite

“…Salgının dağılımı ve sonuçları, hane halkı sayısı, nem, sıcaklık, mevsim, hijyen, sağlık tesislerine erişim ve izolasyon kapasitesi, demografik nüfusun özellikleri, sigara kullanımı, konağın enfeksiyon bulaşma yeteneği, bağışıklık durumu, beslenme durumu, eşlik eden hastalıkların prevalansı, patojenite, bulaşma yolu, bulaşabilirlik özellikleri, virülans faktörleri, vb. gibi çeşitli faktörlere göre değişir (14) . Örneğin, Çin'in Wuhan kentindeki salgının erken dinamiklerine dair başlangıç tahminler, enfekte kişilerin 6-7 gün arasında iki katına çıktığını ve bulaşıcılığı tahmin etmede kullanılan temel üreme sayısının (R0) 2.2-2.7 olduğunu gösterdi.…”

Section: Salgının Kaynağı Ve Yayılımıunclassified

COVID-19 Transmission and Prevention

Türken¹,

Köse²

2020

Terh

View full text Add to dashboard Cite

küresel pandemi olarak ilan edilmiştir. Salgının kaynağı net olarak açıklanamamıştır. Virüsün hayvanlar üzerinde mutasyona uğrayarak insandan insana bulaşma özelliği kazandığı düşünülmektedir. Salgının farklı bölgelerde dağılımı ve sonuçları, iklim, hijyen, nüfus, demografik özellikler, bulaş özellikleri gibi birçok faktöre göre farklılık göstermektedir. Hastalık esas olarak damlacık ve temas yoluyla bulaşmaktadır. Ayrıca aerosolların solunması gibi başka yollar da gösterilmiştir. Enfeksiyonun bulaşma riski, maruziyet türü ve süresine, önleyici önlemlerin kullanımına ve olası bireysel faktörlere göre değişir. Henüz COVID-19'a tamamen etkili olan bir tedavi ya da koruyucu bir aşı yoktur, ancak tedavi ve aşılarla ilgili çalışmalar devam etmektedir. Virüsün toplum içinde yayılmasını engelleyecek en önemli önlemler el hijyeni, sosyal mesafe ve karantinadır. Daha fazla yayılmayı engellemek için erken tarama, tanı, izolasyon ve tedavi gereklidir. Önleyici stratejiler, hastaların izolasyonu ve enfekte bir hastaya teşhis ve klinik bakım sağlanması sırasında alınması gereken uygun önlemler dahil olmak üzere dikkatli enfeksiyon kontrolüne odaklanır.

show abstract

“…The virus spreads primarily through respiratory droplets among people in close contact or through contact with the immediate environment of the infected person [4]. It is highly transmittable, with an estimated reproductive number twice as high as that of the influenza virus [5]. Due to the immense scale of the SARS-CoV-2 epidemic, healthcare systems worldwide are struggling to provide adequate patient care.…”

Section: Introductionmentioning

confidence: 99%

Occupational risks for SARS-CoV-2 infection: the Polish experience

Sierpiński¹,

Pinkas²,

Jankowski³

et al. 2020

Int J Occup Med Environ Health

View full text Add to dashboard Cite

The disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed COVID-19, is asymptomatic or mild in most cases. These patients do not need treatment in hospital and can be isolated at home. To date, most studies have been conducted among inpatients with severe COVID-19. In this study, the authors surveyed patients with mild COVID-19 who remained in home isolation, and analyzed the sources and occupational risk factors for SARS-CoV-2 infections. Material and Methods: This cross-sectional study was carried out on April 17-18, 2020, among patients infected with SARS-CoV-2 who remained in home isolation in Poland. Data were acquired through a structured interview that included questions about the isolation course, symptoms, comorbidities, infection source, household characteristics, occupation, and workplace. Data were presented with descriptive statistics. Results: Of the 4878 patients in home isolation, the authors were able to contact 3313. Of them, 1191 patients declined their invitation, and 2122 agreed to take part. The median age of the patients included in the study was 50 years; 59% were female. Most patients (92%) had not been abroad before the infection. More than half (55%) knew how they became infected; of them, 75% became infected at work. Of all patients, 70% were occupationally active. Nearly half of the occupationally active patients (48%) worked in healthcare, 3% worked in public administration or defense, 3% worked in transportation, and 2% worked in education. Sixty-five percent of the occupationally active patients worked in companies with >100 employees. Conclusions: Most of the patients with COVID-19 in home isolation in Poland were occupationally active, wherein the majority of people who were aware of the source of SARS-CoV-2 infection worked in healthcare. As most of the infected patients worked in companies with >100 employees, which is not a Polish employment pattern, the authors expect that smaller companies may have a lower risk of SARS-CoV-2 infections.

show abstract

Understanding dynamics of pandemics

Cited by 126 publications

References 20 publications

Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy

Effect of the COVID-19 pandemic on drug compliance and stigmatization in patients with epilepsy

COVID-19 Transmission and Prevention

Occupational risks for SARS-CoV-2 infection: the Polish experience

Contact Info

Product

Resources

About